Lonza Group AG Amaxa Nucleofector

Amaxa Nucleofector® 3506 is an advanced electroporation-based transfection system designed to efficiently introduce nucleic acids, such as DNA and RNA, directly into the nucleus and cytoplasm of mammalian cells. This technology is particularly effective for transfecting primary cells and cell lines that are traditionally challenging to transfect, including non-dividing cells like neurons and resting blood cells.

Key features and benefits:

• High transfection efficiency: Achieves superior gene transfer rates in difficult-to-transfect cells.
• Direct nuclear delivery: Facilitates immediate gene expression by delivering nucleic acids directly into the nucleus.
• Versatility: Compatible with a wide range of cell types, including primary cells, stem cells, and various cell lines.
• Preservation of cell functionality: Maintains high cell viability and functionality post-transfection, essential for downstream applications.
• Non-viral method: Reduces safety risks associated with viral vectors, offering a reliable and cost-effective alternative.

Applications span multiple scientific fields:

• Molecular biology: Gene expression studies, gene knockdown experiments.
• Neuroscience: Transfection of neurons for functional analyses.
• Immunology: Manipulation of immune cells for vaccine development and immunotherapy research.
• Stem cell research: Genetic modification of stem cells for regenerative medicine studies.

Commonly utilised in:

• Academic research laboratories: For fundamental studies in cell biology and genetics.
• Biotechnology companies: Involved in drug discovery and development.
• Clinical research institutions: Conducting translational research and developing gene therapies.

Relevance timeline:

First introduced by Amaxa in 2001, the Nucleofector® 3506 system has been widely adopted and remains a critical tool in modern biotechnology and biomedical research.

This system's ability to efficiently transfect challenging cell types while preserving their functionality makes it indispensable for researchers aiming to advance gene editing, cell therapy, and other cutting-edge applications in the biotechnology industry.